Paid Clinical Trials in Orlando

Candace Kastanis

Written by Candace Kastanis

Chemistry B.S. | UC Davis | Clinical Lab Technician

Updated & Fact Checked 3/07/23

Clinical Research in Orlando For Money

Orlando, Florida is known for more than just warmth, Disney World, and Daytona. As it turns out, if you’re looking for an option to supplement income, paid clinical trials for healthy volunteers nearby are abundant in Orlando. Since Florida is growing faster than most states in the U.S. right now, it’s expected this trend will continue, and increasing paid clinical trial opportunities will develop.

Presently, Orlando’s population is 321,427; or thereabout. According to experts, .005% of the total U.S. population needs to be involved in some sort of clinical research trial in order to advance medical science. Multiply that number by 321,427, and statistically, you can expect at least 1,607 local opportunities.

There are around 43 Clinical Research Organizations (CROs) in or around Orlando, and hundreds more throughout the rest of the state. Just near Orlando proper, you can expect each of those CROs to have, on average, 37 individual trial opportunities. Essentially, if you want to give this a chance, you’ve got options.

When you can make money to help advance science, based just on your personal health and willingness to be a participant, that’s a win-win. Following we’ll explore a few other bits of information to help you narrow down your choice of CRO.

Demographic Data of Orlando is Important to Determine Trial Availability

Demographic data helps drive CRO opportunities locally. So paid clinical trials nearby for healthy volunteers will reflect that data.

Presently, Orlando is approximately 57.42% Caucasian (including Hispanic populations), 24.2% African, and 8.06% of locals have multiple ethnic backgrounds. The median age of the city is 33.5. It is made up of 51.98% female residents, and 48.02% male residents.

Tumor-Derived FGF19
Recruiting
Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/03/2024
Locations: Burnett School Biomedical Sciences, Orlando, Florida
Conditions: Colorectal Cancer, Breast Cancer, Healthy
Blood Collection for COM/BSBS
Recruiting
The objective of this biospecimen collection protocol is the acquisition of blood from adult volunteers. These biospecimens will be transferred to the College of Medicine (COM)/Burnett School of Biomedical Sciences (BSBS) research scientists and their research teams for testing according to their separate IRB-approved/exempted protocols. These separate IRBapproved protocols cannot be for genetic testing.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/03/2024
Locations: University of Central Florida, Orlando, Florida
Conditions: Healthy
A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment
Recruiting
The purpose of this study is to assess the drug levels of a single oral dose of repotrectinib in participants with moderate and severe HI, and in healthy matched control participants with normal hepatic function.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
07/10/2024
Locations: Local Institution - 0006, Miami Lakes, Florida +1 locations
Conditions: Hepatic Impairment, Healthy Volunteers
Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Recruiting
The purpose of this study is to assess the drug levels and safety of golcadomide (BMS-986369) in adult participants with moderate and severe Hepatic Impairment (HI), and in matched healthy control participants with normal hepatic function.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
11/01/2024
Locations: Arizona Liver Health, Chandler, Arizona +1 locations
Conditions: Hepatic Impairment, Healthy Volunteers
A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis
Recruiting
The purpose of this study is to assess the effect of severe renal impairment (RI) and end-stage renal disease (ESRD) with intermittent hemodialysis (IHD) on the pharmacokinetics and safety of BMS-986278. This study plans to use a staged design based on RI severity.
Gender:
ALL
Ages:
Between 18 years and 84 years
Trial Updated:
03/11/2025
Locations: Clinical Pharmacology Of Miami, LLC, Miami, Florida +1 locations
Conditions: Kidney Failure, Chronic, Healthy Volunteers, Renal Impairment
A Clinical Study of MK-1084 in Participants With Renal Impairment (MK-1084-010)
Recruiting
The goal of this study is to learn what happens to MK-1084 levels in a person's body over time. Researchers will measure what happens to MK-1084 levels in the body when it is given to people with moderate or severe renal impairment (RI) (meaning the kidneys do not work properly) as compared to people who are in good health. Researchers also want to learn about the safety of MK-1084 when it is given to people with RI and if people with RI can tolerate it.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
06/05/2025
Locations: Orlando Clinical Research Center ( Site 0002), Orlando, Florida
Conditions: Healthy, Renal Impairment
A Varegacestat Hepatic Impairment Study
Recruiting
This clinical trial is designed to determine the pharmacokinetics, safety and tolerability of varegacestat in people with impaired liver function compared to people with normal liver function.
Gender:
ALL
Ages:
Between 18 years and 84 years
Trial Updated:
03/10/2025
Locations: Orlando Clinical Research Center, Orlando, Florida
Conditions: Healthy Volunteer, Hepatic Impairment (HI)
A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function
Recruiting
The main purpose of this study is to evaluate how much lepodisiran gets into the blood stream and how long it takes the body to get rid of it when given as a subcutaneous (SC) injection under the skin to participants with mild, moderate, or severe liver function impairment compared to participants with normal liver function. The study will also evaluate how well lepodisiran is tolerated and what side effects may occur in these participants. The study will last up to approximately 9 weeks, exclu... Read More
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
07/17/2025
Locations: Clinical Pharmacology of Miami, Miami, Florida
Conditions: Liver Dysfunction, Healthy
The Effect of the Menstrual Cycle on Immune Cell Activity and Recovery After Resistance Exercise
Recruiting
The goal of this observational study is to learn how the menstrual cycle affects immune cell activation, recruitment, and recovery responses after resistance exercise in healthy, resistance-trained women aged 18-40. The main questions it aims to answer are: Does the menstrual cycle influence neutrophil recruitment and adhesion after resistance exercise? Does the menstrual cycle affect markers of muscle damage and functional recovery? Researchers will compare three menstrual phases (early follic... Read More
Gender:
FEMALE
Ages:
Between 18 years and 40 years
Trial Updated:
05/14/2025
Locations: University of Central Florida, Orlando, Florida
Conditions: Healthy Women, Menstruation, Resistance Exercise
Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib
Recruiting
The purposes of this study are to determine: * The pharmacokinetics (the amount of study drug in your blood and how long it takes the body to get rid of it) of the study drug and its metabolites (substances produced as the body breaks down the study drug) in participants with moderate or severe liver function impairment compared to participants with normal liver function (also known as a healthy volunteer). Pharmacokinetics (or PK) is the study of how your body absorbs, breaks down, and removes... Read More
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
05/21/2025
Locations: Clinical Pharmacology of Miami, Miami, Florida
Conditions: Healthy, Hepatic Impairment

Exploring Orlando Diversity to Identify Paid Trial Opportunities

What this means is that the lion’s share of paid clinical trials for healthy volunteers in Orlando will be for Caucasian (including Hispanic) females in their early thirties.

Men in similar categories are a close second but keep in mind, that many CROs have studies that require no gender or ethnic background. Also, there will be more diverse studies conducted locally.

We have compiled the following list of paid clinical trials for healthy volunteers, click the Search All button at the bottom to find more:


Multiple Orlando CROs Have Opportunities for Healthy Participants

In order to identify healthy volunteer paid clinical trials which fit your personal requirements, you will want to explore a few known local research groups conducting trial studies. Here are three to consider if you’re not sure exactly where to start:


Notable Breakthroughs Orlando Can Lay Claim To

There are a lot of things going on in Florida medicine generally, and Orlando has always been one of the most advanced cities in terms of cutting-edge developments. Disney World was designed to be a futuristic city, and it’s in Orlando. So you will find some surprising next-generation research going on in this central Floridian metropolis. Consider these recent breakthroughs for background:


Orlando CRO Trial Opportunities: Available, and Cutting-Edge

As a state, Florida is trending in more ways than one, and Orlando is one of its most prominent cities. You’re definitely going to find opportunities to supplement income through paid clinical trials in Orlando. There are plenty of studies to choose from across the city, and beyond helping you keep your bank account healthy, they represent tomorrow’s medical solutions.

This means you’re making money, and you’re taking part in research that will very likely change the world in the coming years. At the end of the day, there’s a lot to recommend if you are looking to participate in clinical research studies.